The Small Animal Imaging (In-Vivo) Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Small Animal Imaging (In-Vivo) Market:
https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report
According to The Business Research Company’s Small Animal Imaging (In-Vivo) Global Market Report 2024, The small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $2.59 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to preclinical research and drug development, expansion of pharmaceutical and biotechnology sectors, growth in translational research, disease modeling and pathophysiology studies, academic and government funding for research.
The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $4.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to development of novel imaging probes and tracers, expansion of preclinical cros (contract research organiations), integration of ai in image analysis, advanced multimodal imaging systems, 3d and high-resolution imaging for small animals, rise in research for rare and orphan diseases.. Major trends in the forecast period include molecular and functional imaging in small animals, longitudinal and real-time in-vivo imaging, hybrid imaging modalities for multimodal information, imaging of crispr-edited animals for genetics research, ai-driven phenotyping and biomarker discovery, imaging for neurodegenerative diseases and neuroscience..
Growing expenditure in the healthcare sector is expected to propel the growth of the small animal imaging (in vivo) market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure and increasing healthcare awareness encourage the concept of self-care management, where PET equipment is used in techniques such as small animal imaging. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Furthermore, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, growing expenditure for the healthcare sector is driving the growth of the small animal imaging (in-vivo) market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp
The small animal imaging (in-vivo) market covered in this report is segmented –
1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers
Technological advancement is a key trend gaining popularity in the small animal imaging (in-vivo) market. Major companies operating in the small animal imaging (in vivo) market are focused on technological advancement to strengthen their position. For instance, in April 2022, PerkinElmer, Inc., a US-based company engaged in business areas such as diagnostics, life science research, and imaging, launched the Vega imaging system, an automated advanced technology ultrasound platform. Automated technology involves the use of two automated transducers, resulting in easy-to-use technology and generating more consistent results to visualize the pathophysiology of the disease.
The small animal imaging (in-vivo) market report table of contents includes:
1. Executive Summary
2. Small Animal Imaging (In-Vivo) Market Characteristics
3. Small Animal Imaging (In-Vivo) Market Trends And Strategies
4. Small Animal Imaging (In-Vivo) Market – Macro Economic Scenario
5. Global Small Animal Imaging (In-Vivo) Market Size and Growth
.
.
.
26. South America Small Animal Imaging (In-Vivo) Market
27. Brazil Small Animal Imaging (In-Vivo) Market
28. Middle East Small Animal Imaging (In-Vivo) Market
29. Africa Small Animal Imaging (In-Vivo) Market
30. Small Animal Imaging (In-Vivo) Market Competitive Landscape And Company Profiles
Top Major Players:
- Bruker Corporation
- PerkinElmer Inc
- Miltenyi Biotec GmbH
- Aspect Imaging Ltd
- Mediso Ltd
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
